1. Home
  2. ACHV vs MPV Comparison

ACHV vs MPV Comparison

Compare ACHV & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.56

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Logo Barings Participation Investors

MPV

Barings Participation Investors

HOLD

Current Price

$17.24

Market Cap

201.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
MPV
Founded
N/A
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
201.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
MPV
Price
$4.56
$17.24
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.6M
13.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
8.71%
EPS Growth
N/A
N/A
EPS
N/A
1.71
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.05
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$15.65
52 Week High
$6.03
$21.00

Technical Indicators

Market Signals
Indicator
ACHV
MPV
Relative Strength Index (RSI) 60.45 42.38
Support Level $4.04 $16.06
Resistance Level $5.13 $19.37
Average True Range (ATR) 0.42 0.37
MACD 0.04 -0.02
Stochastic Oscillator 44.16 18.87

Price Performance

Historical Comparison
ACHV
MPV

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

Share on Social Networks: